Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Liu

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The New England Journal of Medicine|June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell DiseaseHaydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Monoclonal nephritic factors reveal insights into C3 convertase dynamics and dysregulationSeth J Welsh, Christopher T Culek, Zhen Xu, et al.
Science Translational Medicine|February 11, 2021
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responsesYing Kai Chan, Sean K Wang, Colin J Chu, et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The New England Journal of Medicine|June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell DiseaseHaydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Monoclonal nephritic factors reveal insights into C3 convertase dynamics and dysregulationSeth J Welsh, Christopher T Culek, Zhen Xu, et al.
Science Translational Medicine|February 11, 2021
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responsesYing Kai Chan, Sean K Wang, Colin J Chu, et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Pageof 4